Oxygen Self-Production Red Blood Cell Carrier System for MRI Mediated Cancer Therapy: Ferryl-Hb, Sonodynamic, and Chemical Therapy
Authors:
- 18 October 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (12) , 4132-4143
Abstract
Hypoxia in tumors can lead to insufficient oxygen supply during sonodynamic therapy (SDT), which in turn strengthens tumor resistance to sonodynamic efficacy. To conquer hypoxia in tumors and improve the treatment effectiveness, we developed oxygen self-production red blood cell (RBC) carrier system to decompose tumor endogenic H2O2 into O2 and combine triplex cancer therapy: ferryl-hemoglobin (ferryl-Hb), sonodynamic and chemical therapy. Both hydrophilic sonosensitizer and doxorubicin (DOX) were encapsulated inside RBCs (DOX/Mn-TPPS@RBCs). The drug release can be improved by combining the effects of H2O2 and US irradiation. Here, we introduced a contrast agent, meso-tetra (4-sulphonatephenyl) porphyrinate manganese (III) complex (Mn-TPPS), which could be used to enhance the signal intensity of magnetic resonance imaging (MRI) in tumor site. The feasibility of Mn-TPPS as a sonosensitizer was investigated in the SDT. Importantly, DOX/Mn-TPPS@RBCs overcame hypoxia in tumor and improved the efficacy of SDT, owing to the O2 generation by the catalase-catalyzed decomposition of tumor endogenic H2O2. Hemoglobin was simultaneously oxidized into highly oxidative ferryl-Hb species by H2O2 and reactive oxygen species (ROS), resulting in the cytotoxicity. Overall, this drug delivery system is a promising therapeutic agent involving in situ production of oxygen inside the tumor, triplex therapy, and MRI.Keywords
Funding Information
- Natural Science Foundation of Henan Province (22100002)
- Henan Province (52110131)
This publication has 44 references indexed in Scilit:
- A visual guide to gene/optothermal synergy therapy nanosystem using tungsten oxideJournal of Colloid and Interface Science, 2017
- A Smart Responsive Dual Aptamers‐Targeted Bubble‐Generating Nanosystem for Cancer Triplex Therapy and Ultrasound ImagingSmall, 2017
- A “win–win” nanoplatform: TiO 2 :Yb,Ho,F for NIR light-induced synergistic therapy and imagingNanoscale, 2017
- Metalloporphyrin-Encapsulated Biodegradable Nanosystems for Highly Efficient Magnetic Resonance Imaging-Guided Sonodynamic Cancer TherapyJournal of the American Chemical Society, 2017
- A multifunctional nanoparticle system combines sonodynamic therapy and chemotherapy to treat hepatocellular carcinomaNano Research, 2017
- Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumoursJournal of Controlled Release, 2015
- The impact of hypoxia in pancreatic cancer invasion and metastasisHypoxia, 2014
- Understanding, recognizing, and managing toxicities of targeted anticancer therapiesCA: A Cancer Journal for Clinicians, 2013
- The tumor affinity of chlorin e6 and its sonodynamic effects on non-small cell lung cancerUltrasonics Sonochemistry, 2013
- The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cellsUltrasonics, 2013